Most Japanese medical workers still not fully vaccinated as Olympics loom By Reuters


© Reuters. FILE PHOTO: Security personnel stand guard near the Olympic rings monument during a rally by anti-Olympics protesters outside the Japanese Olympic Committee headquarters, amid the coronavirus disease (COVID-19) outbreak, in Tokyo, Japan May 18, 2021. REUT

By Rocky Swift

TOKYO (Reuters) – Less than 30% of Japan’s medics have been vaccinated against COVID-19 in major cities with just 65 days to go before the start of the Tokyo Olympics, the newspaper reported on Wednesday, amid growing calls for the Games to be cancelled.

Cabinet figures released this week showed that three months into Japan’s COVID-19 vaccination push, less than 40% of all medical workers in the country were fully inoculated.

The problem is especially pronounced in Games host-city Tokyo and other large population centres, where the rate of fully vaccinated medical workers was less than 30%, the Nikkei reported.

Much of the supply of vaccine was concentrated in large hospitals, and there had been problems in the reservation systems for medical staff, the newspaper said.

The slow rollout for doctors and nurses has been among complaints cited by medical groups that have come out against holding the Games as Japan battles to contain a surge in infections.

The government is aiming to inoculate most of its 36 million people over the age of 65 by the end of July. To reach that target, the government hopes to deliver about 1 million shots a day, about three times faster than the current pace.

So far, just 3.7% of Japan’s population of 126 million have gotten at least one COVID-19 vaccine shot, the lowest rate among wealthy countries. Initially, the holdup was scant supplies of the vaccine developed by Pfizer Inc (NYSE:) and BioNTech SE (NASDAQ:), the only one approved by regulators so far.

But inbound shipments of the Pfizer shot have increased dramatically in May, and the government is expected to approve Moderna (NASDAQ:) Inc’s candidate this week for use in mass vaccination centres.

The shot developed by AstraZeneca (NASDAQ:) PLC is also being considered by domestic regulators.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Stay connected with us on social media platform for instant update click here to join our  Twitter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

For all the latest Education News Click Here 

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! TechiLive.in is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.